Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Government Contract opportunity from Department Of Defense was posted on June 14, 2021. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

66--ECAT Branch - Philadelphia

Awarded
SPE2DE19R0001Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

AI Contract Overview

Show more

The Department of Defense, through DLA Troop Support, is establishing a five-year indefinite delivery, indefinite quantity contract for the procurement of NuVasive spinal procedural packages. This action is being conducted under the ECAT Manufacturer Direct Program with an estimated total value of approximately 43 million dollars. The procurement is categorized under NAICS code 423450 and is managed by the ECAT Branch located in Philadelphia, Pennsylvania. Due to the proprietary nature of the products and the specialized support required, this contract is being awarded as a justification for other than full and open competition. Citing 10 U.S.C. 2304(c)(1) and FAR 6.302-1, the agency has determined that NuVasive is the only responsible source capable of fulfilling the specific requirements of this procurement.

General Info

Contract Value

$0

NAICS

423450 - Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers

Place of Performance

PA, USA

Set-Aside

NONE

Award Issued Date

Documents

1

NuVasive Spinal Procedural Packages Justification

PDF, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Contract not broken down yet

CLEATUS splits the solicitation into Uniform Contract Format (UCF) sections: scope, pricing, deliverables, and evaluation criteria.

Timeline

PhaseAwarded
Posted

Sources Sought

Type Changed

Sources Sought → Combined Synopsis

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → DLA Troop Support
Contacts1 person available
OfficePHILADELPHIA, PA, 19111-5092, USA
Office AddressPHILADELPHIA, PA, 19111-5092, USA
Contacts

Full Description

Show more
The goal of the Manufacturer Direct Program is to establish an alternatives to manual market purchase activity, re-engineer the business process with an automated e-commerce business solution. The objective of this solicitation is to establish a Fixed Price (with Economic Price Adjustment) Indefinite Delivery/Indefinite Quantity (IDIQ) contract for NuVasive's spinal orthopedic "procedural packages", which includes the implant, instrumentation sets, orthobiological products and ancillary accessories that are necessary for the physician to perform orthopedic surgery. This solicitation contains an on-site personnel requirement for the contractor to provide advice and guidance to physician's before, during and after implantation of the device at the request of the Medical Treatment Facility (MTF). Technical support shall be available twenty-four (24) hours a day, (7) seven days a week. Market research has revealed that there are no other manufacturers or distributors other than NuVasive who can provide Department of Defense (DoD) hospitals with the NuVasive spinal "procedural package" at the required time of surgery and be available on-site if needed to answer questions on all these products. The NuVasive spine representatives are experts in NuVasive's products and are a vital part in helping to ensure that the patient is getting the necessary treatment. NuVasive will have their product line loaded into the DLA Troop Support Medical Electronic Catalog (ECAT). All orders, order acknowledgements and invoice transactions are required to be electronic. Items will be delivered to various DoD research centers, hospitals and clinics and any federal customer participating in this program. The terms of the contract will be a one-year base ordering period and four one-year unilateral option ordering periods. This procurement has an estimated value of $8,500,00.00 for the base ordering period, $8,558,650.00 for option ordering period one, $8,617,704.69 for option ordering period two, $8,677,166.85 for option ordering period three and $8,737,039.30 for option ordering period four for a total estimate of $43,090,560.84 over the five year life of the procurement. The contract maximum is $136,875,899.11 over the five year life of the contract. Solicitation SPE2DE19R0001 is expected to be issued by June 1, 2019 and can be found on the DLA Internet Bid Board System (DIBBS) at https;//www.dibbs.bsm.dla.mil . The point of contact is Charles Reimer, DLA Troop Support, +1 (555) 000-0000. The solicitation may not become available until the solicitation issue date.

More opportunities from Department Of Defense → DLA Troop Support

Same awarding agency

NAICS: 326199
New
Federal
Synopsis for Outserts (NSN - 4240-01-529-8327 & 4240-01-528-9288)
Solicitation # 015298327_015289288
Solicitation SPE8EG-26-R-0003 is an unrestricted, fixed-price with economic price adjustment, indefinite delivery/indefinite quantity contract issued by DLA Troop Support for the procurement of critical Chemical Biological Radiation and Nuclear Personal Protective Equipment. The requirement consists of two National Stock Numbers: Clear Assembly Outserts (NSN 4240-01-529-8327) and Laser Assembly Outserts (NSN 4240-01-528-9288). The contract structure includes a one-year base period with four one-year option periods. Delivery terms are FOB Origin, with inspection and acceptance also occurring at origin. Price is the sole evaluated factor for award. Avon Protection Systems Incorporated is the approved source for these items. Due to the critical nature of the application, only approved part numbers are authorized unless a complete data package for an alternate is provided for evaluation. The procurement is subject to strict export controls under ITAR and EAR, requiring offerors to have an approved US/Canada Joint Certification Program certification and DLA authorization to access technical data. Additionally, while Cybersecurity Maturity Model Certification Level 2 requirements apply to these materials, they are not required for the initial award but will be necessary for future continued performance. The solicitation closing date has been extended multiple times and is currently set for November 13, 2026, at 3:00 PM EDT.
All Other Plastics Product Manufacturing

POSTED

about 15 hours ago

DEADLINE

in 15 days
View Details
NAICS: 325412
New
Federal
Atropine Auto-Injector
Solicitation # SPE2DP-27-R-ATRO
DLA Troop Support is conducting market research via a sources sought notice for the procurement of Atropine Auto-Injectors under solicitation SPE2DP-27-ATRO. The agency intends to award a firm-fixed price, indefinite delivery, indefinite quantity contract consisting of a one-year base term and four one-year option terms. The required devices must deliver 1.67 mg of atropine base (equivalent to 2 mg atropine sulfate) and be 99.5 percent reliable, with a dispensing time of 0.5 seconds and an activation force between 0.90 and 3.60 kg. All products must be FDA approved per NDA No. 212319, comply with USP sterility standards, and maintain a minimum shelf life of 24 months upon delivery to DLA Distribution Susquehanna in New Cumberland, Pennsylvania. Strict packaging and marking requirements are mandated, including individual sealed polyethylene bags, intermediate boxes of 40 units, and exterior containers of 480 units, all conforming to MIL-STD-2073-1 and ASTM D4169-16. Labels must include specific dosage, storage, and usage instructions for nerve agent and insecticide poisoning. Interested respondents must provide their CAGE code, business size under NAICS 325412, and certification of commerciality per FAR 2.101. Manufacturers must submit FDA registration, while authorized distributors must provide a letter of commitment from the manufacturer. Responses are due by December 1, 2026.
Pharmaceutical Preparation Manufacturing

POSTED

about 15 hours ago

DEADLINE

in about 1 month
View Details

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS